BioSpace News Archive

Career Advice

Just Keep Swimming: How to Cope With Rejection on the Job Market

Whether you’ve been on the job market for a few weeks, months, or in the case of some academic positions maybe even years, being passed over for opportunities time and time again can really do a number on your morale and confidence level.

May 31, 2018

·

3 min read

Pictured: Pile of money/iStock, Ihor Lukianenko

Biotech Bay

Alzheimer’s Company Cortexyme Closes $76 Million Series B Financing Round with Pfizer, Takeda and Google Participating

South San Francisco-based Cortexyme closed on a $76 million Series B financing round.

May 31, 2018

·

2 min read

·

Mark Terry

Biotech Beach

June 1st Research Roundup

There are plenty of great scientific research stories out this week from a tool to delete gene products to the growth of whole muscles incorporated into a biohybrid robot. Here’s a look at just a few of them.

May 31, 2018

·

5 min read

·

Mark Terry

Business

A Look at A Few Hot New Approaches and News in the Research Imaging Market

Advances in data storage and processing, as well as biomarker identification, has led to cutting-edge breakthroughs in clinical and research imaging technology. Here’s a look at just a few of these stories.

May 31, 2018

·

4 min read

·

Mark Terry

Deals

U.S. Justice Department Gives Bayer and Monsanto Go-Ahead for Merger

U.S. Justice Department gave the merger the go-ahead after Monsanto agreed to sell approximately $9 billion in assets.

May 31, 2018

·

2 min read

·

Mark Terry

J&J Terminates RA and Leukemia Drug From Pipeline

Drug Development

Johnson & Johnson’s Esketamine Shows Promise in Depression Clinical Trials

The Janssen Pharmaceutical Companies, part of Johnson & Johnson, announced results from two long-term Phase III trials of esketamine nasal spray.

May 31, 2018

·

3 min read

·

Mark Terry

Business

FDA Chains Clinical Hold on CRISPR/ Vertex Sickle Cell Disease IND

Shares of CRISPR Therapeutics plunged dramatically Wednesday after the U.S. Food and Drug Administration placed a clinical hold on a planned sickle cell disease treatment the company was in the process of developing with Vertex Pharmaceuticals.

May 31, 2018

·

2 min read

·

Alex Keown

Gilead's $12B Bet Pays Off in Two Months After the

Drug Development

Primary Endpoint Hit: Gilead and Galapagos’ JAK1 Inhibitor for Arthritis Positive in Phase II

Gilead Sciences and its development partner Galapagos NV announced positive data from its Phase II EQUATOR trial of filgotinib in psoriatic arthritis.

May 31, 2018

·

3 min read

·

Mark Terry

Love Your Job but Hate Your Boss?

A bad boss can quickly sour even the best jobs. Employees are often put in the difficult situation of working for a company, on a project, or with a team that they love while simultaneously having to contend with a difficult boss.

May 31, 2018

·

4 min read

Policy

Challenge Accepted! FDA Launches Innovation Challenge to Help Curb Opioid Abuse

With the ever-increasing concerns of the opioid crisis facing the United States, the U.S. Food and Drug Administration has launched an “innovation challenge” to spur on the development of medical devices that can combat the crisis and help prevent and treat opioid use disorder.

May 31, 2018

·

2 min read

·

Alex Keown